Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets
In this episode of Clinical Trialblazers, Lyla Bibi, Partner at Goldman Sachs and Head of Healthcare Equity Capital Markets, shares her impactful career journey focused on helping bring cutting-edge therapies to life by bridging capital and science. Tune in as she offers a behind-the-scenes look into the nuances of biotech investment in today’s competitive landscape, emphasizing the importance of a clear value proposition, the enduring power of trust in leadership, and the essential characteristics of successful biotech CEOs. Beyond the science and market trends, Lyla offers valuable insights on balancing a demanding career with a full personal life and her optimistic outlook on the future of scientific funding.
Related Insights
CTB Podcast
The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
Jul 14, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
Related Insights
CTB Podcast
The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
Jul 14, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025